teaser
Tina Hawkins
Rheumatology Pharmacist, Leeds Teaching Hospital NHS Trust
Professor Paul Emery
President of European League Against Rheumatism, Arthritis UK Professor of Rhematology, University of Leeds, UK
Rheumatoid arthritis (RA) is a long-term, chronic,
autoimmune condition characterised by inflammation of the synovial joints combined with a number of systemic features resulting from abnormal immune response and secondary inflammation. Uncontrolled disease may result in significant morbidity and mortality.1 Early intervention with disease modifying anti-rheumatic drugs (DMARDs) is essential to prevent long term joint damage, reduce morbidity and improve the patient
